Sangamo Therapeutics
SGMO
#9506
Rank
S$0.11 B
Marketcap
S$0.28
Share price
0.00%
Change (1 day)
-56.83%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: S$0.11 Billion

As of June 2026 Sangamo Therapeutics has a market cap of S$0.11 Billion. This makes Sangamo Therapeutics the world's 9506th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.11 B-36%
2025S$0.18 B-74.71%
2024S$0.72 B470.55%
2023S$0.12 B-81.55%
2022S$0.68 B-53.3%
2021S$1.47 B-49.42%
2020S$2.91 B123.13%
2019S$1.30 B-18.34%
2018S$1.60 B-13.56%
2017S$1.85 B494.69%
2016S$0.31 B-65.69%
2015S$0.90 B-34.54%
2014S$1.38 B26.71%
2013S$1.09 B180.9%
2012S$0.38 B102.06%
2011S$0.19 B-50.28%
2010S$0.38 B3.79%
2009S$0.37 B83.36%
2008S$0.20 B-73%
2007S$0.75 B112.98%
2006S$0.35 B72.9%
2005S$0.20 B-17.07%
2004S$0.24 B6.66%
2003S$0.23 B79.48%
2002S$0.12 B-69.47%
2001S$0.42 B-43.45%
2000S$0.74 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$722.40 B 614,675.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$243.24 B 206,904.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$37.18 B 31,541.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S$31.56 B 26,762.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$206.74 B 175,843.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$384.62 B 327,218.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$52.16 B 44,292.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$14.14 B 11,938.98%๐Ÿ‡บ๐Ÿ‡ธ USA